Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY

(HZNP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
11/22Horizon Therapeutics Says Phase 2/3 Data Support Efficacy of Uplizna in NMOSD Patients ..
MT
11/22New Analysis Published in Multiple Sclerosis and Related Disorders Supports the Efficac..
BU
11/22Horizon Therapeutics plc Announces That A New Post Hoc Analysis of the UPLIZNA N-Moment..
CI
11/19Goldman Sachs Upgrades Horizon Therapeutics to Buy From Neutral; Price Target is $168
MT
11/15Horizon Therapeutics plc Receives CHMP Positive Opinion for UPLIZNA (inebilizumab) as a..
AQ
11/15Horizon Therapeutics plc - New Real-World Data Show High Rate of Patient Adherence to T..
AQ
11/15Horizon Therapeutics Recognizes Second Annual Thyroid Eye Disease (TED) Awareness Week ..
BU
11/12Horizon Therapeutics Says Data Show 'High Rate of Patient Adherence' to Tepezza for Thy..
MT
11/12New Real-World Data Show High Rate of Patient Adherence to TEPEZZA® (teprotumumab-trbw)..
BU
11/12Horizon Therapeutics plc announces findings of a real-world adherence analysis of TEPEZ..
CI
11/12Horizon Therapeutics plc Receives CHMP Positive Opinion for UPLIZNA® (inebilizumab) as ..
BU
11/12Horizon Therapeutics plc Receives CHMP Positive Opinion for UPLIZNA? (inebilizumab) as ..
CI
11/09Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2b Pivotal Trial Eva..
BU
11/09Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2B Pivotal Trial Eva..
CI
11/08Horizon Therapeutics plc to Participate in Upcoming Investor Conferences
BU
11/08Horizon Therapeutics plc Receives Top Workplace Awards in Chicago and San Francisco
AQ
11/08INSIDER SELL : Horizon Therapeutics Public Ltd
MT
11/05Horizon Therapeutics - Results from PROTECT Trial Evaluating KRYSTEXXA (pegloticase inj..
AQ
11/05Horizon Therapeutics plc Receives Top Workplace Awards in Chicago and San Francisco
BU
11/04Horizon Therapeutics Study of Krystexxa in Treatment of Gout in Kidney Transplant Patie..
MT
11/04Results from PROTECT Trial Evaluating KRYSTEXXA® (pegloticase injection) in Kidney Tran..
BU
11/04Horizon Therapeutics plc Announces the Presentation of Results from the Completed PROTE..
CI
11/03INSIDER SELL : Horizon Therapeutics Public Ltd
MT
11/03Horizon Therapeutics Public Limited Company Announces Management Changes
CI
11/03Health Care Stocks Mixed Premarket Wednesday
MT
11/03Horizon Therapeutics Q3 Adjusted Earnings, Net Sales Rise; Names New CFO
MT
11/03HORIZON THERAPEUTICS : Q3 Earnings Snapshot
AQ
11/03Horizon Therapeutics plc Reports Record Third-Quarter 2021 Financial Results; Increasin..
PU
11/03Horizon Therapeutics Public Limited Company Reports Earnings Results for the Third Quar..
CI
11/03Earnings Flash (HZNP) HORIZON THERAPEUTICS Reports Q3 EPS $1.75, vs. Street Est of $1.5..
MT
11/03Earnings Flash (HZNP) HORIZON THERAPEUTICS Reports Q3 Revenue $1.04B, vs. Street Est of..
MT
11/03Horizon Therapeutics plc Announces Chief Financial Officer Succession Plan
BU
11/03Horizon Therapeutics plc Reports Record Third-Quarter 2021 Financial Results; Increasin..
BU
11/03Horizon Therapeutics plc Announces Chief Financial Officer Changes
CI
11/03Horizon Therapeutics Public Limited Company Provides Earnings Guidance for the Full Yea..
CI
11/01New Data Being Presented at American College of Rheumatology Convergence 2021 Highlight..
BU
11/01Horizon Therapeutics plc Announces Presentations on Results from New Survey of Practici..
CI
10/26Horizon Therapeutics - MIRROR Randomized Controlled Trial Meets Primary Endpoint and Sh..
AQ
10/25HORIZON THERAPEUTICS PUBLIC : ' Gout Drug Trial Meets Primary Endpoint
MT
10/25HORIZON THERAPEUTICS PUBLIC : MIRROR Randomized Controlled Trial Meets Primary Endpoint an..
BU
10/25Horizon Therapeutics Public Limited Company Announces Mirror Randomized Controlled Tria..
CI
10/25HORIZON THERAPEUTICS PUBLIC : plc Named to Newsweek's List of the Most Loved Workplaces fo..
AQ
10/22HORIZON THERAPEUTICS PLC : Named to Newsweek's List of the Most Loved Workplaces for 2021
BU
10/22HORIZON THERAPEUTICS PUBLIC : plc. - Newly Published Data Continue to Support Long-Term Ef..
AQ
10/21HORIZON THERAPEUTICS PUBLIC : Says New Data Backing Thyroid Eye Disease Drug Long-Term Eff..
MT
10/21HORIZON THERAPEUTICS PUBLIC : Newly Published Data Continue to Support Long-Term Efficacy ..
BU
10/21Horizon Therapeutics plc Announces Additional Data Supporting the Long-Term Efficacy of..
CI
10/14HORIZON THERAPEUTICS PUBLIC : plc - New Data Reinforce the Relationship Between B-Cell Dep..
AQ
10/13HORIZON THERAPEUTICS PUBLIC : - New TEPEZZA (teprotumumab-trbw) Data to be Presented at th..
AQ
10/13HORIZON THERAPEUTICS PUBLIC : New Data Reinforce the Relationship Between B-Cell Depletion..
BU
10/13Horizon Therapeutics plc Announces Results from A New Analysis of the UPLIZNA Pivotal P..
CI
10/12HORIZON THERAPEUTICS PUBLIC : New TEPEZZA® (teprotumumab-trbw) Data to be Presented at the..
BU
10/11HORIZON THERAPEUTICS PLC : to Release Third-Quarter 2021 Financial Results and Host Webcas..
BU
10/06HORIZON THERAPEUTICS PLC : Named One of the 2021 Top 100 Adoption-Friendly Workplaces by t..
BU
10/05HORIZON THERAPEUTICS PUBLIC : plc - New Analysis Published in Multiple Sclerosis Journal A..
AQ
10/05HORIZON THERAPEUTICS PUBLIC : plc Announces New UPLIZNA (inebilizumab-cdon) Data in Neurom..
AQ
10/04HORIZON THERAPEUTICS PUBLIC : New Analysis Published in Multiple Sclerosis Journal Assesse..
BU
10/04HORIZON THERAPEUTICS PLC : Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyeliti..
BU
10/04Horizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelit..
CI
10/01INSIDER SELL : Horizon Therapeutics
MT
09/29HORIZON THERAPEUTICS PLC : Announces New Development Programs at Virtual R&D Day
BU
09/29Horizon Therapeutics plc Announces New Development Programs At Virtual R&D Day
CI
09/23INSIDER SELL : Horizon Therapeutics Public Ltd
MT
09/23HORIZON THERAPEUTICS PUBLIC : Says Uplizna May Provide Durable Efficacy for African Americ..
MT
09/23HORIZON THERAPEUTICS PUBLIC :  Horizon Therapeutics plc Announces Agenda for Virtual R&D D..
BU
09/23HORIZON THERAPEUTICS PLC : Announces Data Showing UPLIZNA® (inebilizumab-cdon) Also Produc..
BU
09/23Horizon Therapeutics Public Limited Company Announces Data Showing UPLIZNA Also Produce..
CI
09/21HORIZON THERAPEUTICS PUBLIC : Partner HemoShear Advancing Several Novel Compounds
MT
09/21HORIZON THERAPEUTICS PLC : Announces New Genetic Counselor Curated Algorithms and Next-Gen..
BU
09/21HEMOSHEAR THERAPEUTICS : Advancing Several Novel Compounds for Horizon Therapeutics plc Go..
PR
09/20INSIDER SELL : Horizon Therapeutics Public Ltd
MT
09/16HORIZON THERAPEUTICS PLC : Named One of the 2021 Best Workplaces for Women™ by Fortu..
BU
09/14INSIDER SELL : Horizon Therapeutics Public Ltd
MT
09/07HORIZON THERAPEUTICS PUBLIC : Begins Enrollment in Clinical Trial of Tepezz in Chronic Thy..
MT
09/07HORIZON THERAPEUTICS PUBLIC :  Horizon Therapeutics plc Initiates Randomized Controlled Cl..
BU
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
11/30/21